wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q21134707-9D81B700-A19F-4FD0-ACCF-7A6E06CC8853
Q21134707-9D81B700-A19F-4FD0-ACCF-7A6E06CC8853
BestRank
Statement
http://www.wikidata.org/entity/statement/Q21134707-9D81B700-A19F-4FD0-ACCF-7A6E06CC8853
S100A9 interaction with TLR4 promotes tumor growth
P2860
Q21134707-9D81B700-A19F-4FD0-ACCF-7A6E06CC8853
BestRank
Statement
http://www.wikidata.org/entity/statement/Q21134707-9D81B700-A19F-4FD0-ACCF-7A6E06CC8853
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
b96791967985267a5407c672c84662e161f6e517
P2860
Phase II randomized, double-blind, placebo-controlled study of tasquinimod in men with minimally symptomatic metastatic castrate-resistant prostate cancer.